OSCR Stock Analysis: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$14.35
-0.58 (-3.88%)
βΌ
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
9d
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
10 traders called OSCR this week
53% bullish • 9 bearish
53% bullish • 9 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π HOLD: OSCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
π HOLD: OSCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $14.35, which is considered oversold relative to its 30-day fair value range of $14.70 to $16.81.
Technical Outlook: Technically, OSCR is in a downtrend. The price is currently testing key support at $14.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OSCR is in a downtrend. The price is currently testing key support at $14.56. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$14.70 -
$16.81
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
Protect Your Profits
Holding OSCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- NEUTRAL: Near Wall St target ($15.78)
- CAUTION: Recommendation downgraded due to -8.5% 5-day decline
Fair Price Analysis
30-Day Fair Range
$14.70 -
$16.81
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$14.56
Resistance Level
$17.47
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
4147.22
Wall Street Target
$15.78
(+5.7%)
Revenue Growth (YoY)
23.2%
Earnings Growth (YoY)
47.2%
Profit Margin
-2.2%
Last updated: January 31, 2026 1:32 AM ET
Data refreshes hourly during market hours. Next update: 2:32 AM
Data refreshes hourly during market hours. Next update: 2:32 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mario Schlosser
SELL
395000 shares
2025-09-22
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$95 | 61 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$327 | 58 HOLD |
|
UNH
UnitedHealth Group Incor⦠|
STRONG BUY
27 analysts |
$394 | 47 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$395 | 53 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$288 | 62 BUY |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.